Region Skane

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

5 drugs in development

Approved1

Phase 22

Phase 11

Preclinical4

By Therapeutic Area

top 6

Nephrology

222%

Metabolic & Endocrine

111%

Cardiovascular

111%

Respiratory

111%

Neurology

111%

Musculoskeletal

111%

R&D Momentum

71/100

Pipeline Velocity

39/100

Trial Completion Rate

86/100

Pipeline Concentration

16/100

Pipeline Freshness

71/100

Strategic Signals

↗Early-stage heavy pipeline may seek late-stage partners
↗Active in Metabolic & Endocrine but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 19, 2026

Recruiting

Protocolized Reduction of Non-resuscitation Fluids Versus Usual Care in Septic Shock Patients

Sep 15, 2026

Active, not recruiting

Swedish Trial on Embolization of Middle Meningeal Artery Versus Surgical Evacuation in Chronic Subdural Hematoma

Earlier

Sep 4, 2026TrialLow Calorie Diet Before Liver Surgery - A Nordic Multicentre Randomized Controlled Trial

Sep 3, 2026TrialLower Extremity Graft Study (LEGS): A Multicentre Randomised Controlled Trial of Negative Pressure Wound Therapy Versus Conventional Dressings for Split-thickness Skin Grafts After Lower Leg Skin Tumour Excision

Sep 2, 2026TrialThe With Or Without Olecranon K-wire (WOW OK) Trial of Tension Band Wire Fixation Versus Cerclage Fixation Without K-wires in Displaced Stable Olecranon Fractures

Aug 22, 2026TrialBiomarkers After Out-of-hospital Cardiac Arrest- a STEPCARE Substudy

Aug 22, 2026TrialLate Biomarkers in Adult Survivors After Out-of-hospital Cardiac Arrest

Aug 22, 2026TrialFermented Vegan Optimized Diet in Health and Colitis

3 more events

Aug 20, 2026TrialVisual and Auditory Distraction for the Relief of Pain and Anxiety

Aug 20, 2026TrialEffect of L-menthol on Breathlessness and Exercise Capacity in Asthma: a Randomized Crossover Trial

Aug 15, 2026TrialSkin Pigment Type, Phototype and Photodamage Determination Using Image Analyses Powered by Artificial Intelligence - SPAI Study

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Metabolic & Endocrine(1 drug)

—

Metabolic & Endocrine(1 drug)

Musculoskeletal(1 drug)

—

Musculoskeletal(1 drug)

Nephrology(2 drugs)

—

Nephrology(2 drugs)

Neurology(1 drug)

—

Neurology(1 drug)

Respiratory(1 drug)

—

Respiratory(1 drug)

Unknown / Other(2 drugs)

—

Unknown / Other(2 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)